Remogliflozin Etabonate-impurities | Pharmaffiliates

Remogliflozin Etabonate

Remogliflozin Etabonate has been used in trials studying the treatment and basic science of Type 2 Diabetes Mellitus and Diabetes Mellitus, Type 2.Reference standards of Remogliflozin Etabonate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Remogliflozin Etabonate - API Standards 
    [catalogue_number] => PA 18 99000
    [category_ids] => ,78,70,82,
    [chemical_name] => 
    [weight] => 522.60
    [form] => C26H38N2O9
    [cas] => 442201-24-3
    [pslug] => 442201-24-3-remogliflozin-etabonate-api-pa1899000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 18 99000

Remogliflozin Etabonate - API Standards


  • Catalogue No.:PA 18 99000

  • CAS :

    442201-24-3

  • Molecular Formula : C26H38N2O9

  • Molecular Weight : 522.60